ROYAL PRIMARY CARE BROOKLYN — All Prescriptions & Medications — Page 3
Practice Code: C81052 | HEANOR, DE75 7AL
Showing results 101-150 of 553
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Diltiazem hydrochloride | 324 | 18.7K | £3.8K | +5.5% ▲ |
| Loperamide hydrochloride | 323 | 36.5K | £1.2K | +38.7% ▲ |
| Lisinopril | 311 | 15.6K | £350 | -71.6% ▼ |
| Aripiprazole | 311 | 7,035 | £1.0K | +22.2% ▲ |
| Digoxin | 307 | 14.9K | £1.1K | -18.9% ▼ |
| Sacubitril/valsartan | 299 | 20.0K | £32.6K | +24.9% ▲ |
| Promethazine hydrochloride | 299 | 10.6K | £1.3K | -16.3% ▼ |
| Rivaroxaban | 298 | 12.9K | £8.4K | -51.3% ▼ |
| Medroxyprogesterone acetate | 292 | 295 | £1.7K | +141.9% ▲ |
| Cyclizine hydrochloride | 290 | 11.0K | £395 | +79.8% ▲ |
| Lercanidipine hydrochloride | 289 | 11.5K | £1.3K | -53.2% ▼ |
| Buprenorphine | 280 | 2,936 | £3.8K | -23.6% ▼ |
| Mometasone furoate | 275 | 323 | £2.5K | -31.5% ▼ |
| Combined ethinylestradiol 30mcg | 274 | 22.1K | £813 | -1.4% vs avg |
| Latanoprost | 270 | 5,583 | £1.9K | -44.4% ▼ |
| Loratadine | 267 | 15.3K | £336 | +27.8% ▲ |
| Solifenacin | 267 | 12.4K | £469 | -44.0% ▼ |
| Baclofen | 266 | 41.4K | £704 | +32.8% ▲ |
| Thiamine hydrochloride | 263 | 11.2K | £291 | -50.1% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 258 | 25.9K | £1.0K | -15.8% ▼ |
| Mebeverine hydrochloride | 257 | 26.5K | £875 | -17.2% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 252 | 33.4K | £2.2K | +66.7% ▲ |
| Risperidone | 251 | 8,027 | £2.1K | -0.8% vs avg |
| 241 | 3,950 | £843 | +15.3% ▲ | |
| Insulin aspart | 239 | 1,524 | £8.9K | -37.2% ▼ |
| Memantine hydrochloride | 238 | 9,550 | £1.9K | -28.0% ▼ |
| Alogliptin | 237 | 11.5K | £10.4K | -6.5% ▼ |
| Oxycodone hydrochloride | 234 | 11.1K | £1.8K | -8.6% ▼ |
| Other emollient preparations | 234 | 127.5K | £1.6K | -61.0% ▼ |
| Quinine sulfate | 233 | 6,839 | £1.1K | -19.5% ▼ |
| 232 | 2,905 | £952 | -7.0% ▼ | |
| 231 | 1,023 | £426 | +4.8% ▲ | |
| Linagliptin | 229 | 10.1K | £11.4K | -44.1% ▼ |
| Paroxetine hydrochloride | 226 | 11.1K | £476 | +21.1% ▲ |
| Pizotifen malate | 215 | 18.4K | £818 | +160.9% ▲ |
| Nortriptyline | 211 | 17.3K | £1.0K | +45.0% ▲ |
| Enalapril maleate | 208 | 13.7K | £413 | +15.8% ▲ |
| Topiramate | 206 | 15.0K | £864 | +15.9% ▲ |
| Bisacodyl | 205 | 10.7K | £541 | +56.4% ▲ |
| Calcipotriol | 203 | 16.5K | £7.5K | +19.2% ▲ |
| Progesterone | 202 | 15.4K | £2.8K | -51.7% ▼ |
| Sodium valproate | 200 | 32.8K | £3.6K | -37.1% ▼ |
| Estradiol | 200 | 5,102 | £2.8K | -25.9% ▼ |
| Donepezil hydrochloride | 198 | 6,350 | £307 | -35.8% ▼ |
| Mirabegron | 194 | 6,606 | £6.1K | -51.7% ▼ |
| 194 | 3,860 | £1.7K | -70.8% ▼ | |
| Rosuvastatin calcium | 191 | 7,652 | £228 | -78.7% ▼ |
| Haloperidol | 190 | 4,571 | £10.8K | +298.9% ▲ |
| Clobetasone butyrate | 188 | 9,840 | £1.0K | -7.9% ▼ |
| Lorazepam | 187 | 9,224 | £1.4K | +31.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.